Published in Breast on July 07, 2005
Pseudoangiomatous Stromal Hyperplasia: A Rare Cause of Idiopathic Gigantomastia. Plast Reconstr Surg Glob Open (2015) 0.90
Gestational gigantomastia with complete resolution in a Nigerian woman. BMJ Case Rep (2011) 0.89
Gestational Gigantomastia Complicating Pregnancy: A Case Report and Review of the Literature. Case Rep Obstet Gynecol (2015) 0.79
Ectopic Axillary Breast during Systemic Lupus. Case Rep Med (2012) 0.75
Anatomical basis of pedicles in breast reduction. Gland Surg (2017) 0.75
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet (1991) 4.09
Stress and relapse of breast cancer. BMJ (1989) 3.07
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. Eur J Cancer (1992) 2.67
Familial breast cancer. BMJ (1994) 2.54
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol (2001) 2.51
Who needs steroid receptor assays? Lancet (1989) 2.27
Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg (1989) 2.23
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res (1995) 1.96
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr (1992) 1.89
Smoking and prognosis in women with breast cancer. Int J Clin Pract (2005) 1.72
A controlled trial of short-term versus standard axillary drainage after axillary clearance and iridium implant treatment of early breast cancer. Ann R Coll Surg Engl (1991) 1.72
Male breast cancer. Int J Clin Pract (2000) 1.51
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol (2001) 1.44
Surgical correction of gynaecomastia in bodybuilders. Br J Clin Pract (1995) 1.43
Follow-up of patients with aspirated breast cysts is necessary. Arch Surg (1989) 1.41
Why do older women delay presentation with breast cancer symptoms? Psychooncology (2006) 1.40
Additional copies of 1q in sequential samples from a phyllodes tumor of the breast. Cancer Genet Cytogenet (1995) 1.40
A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer (2005) 1.40
Contralateral relapse after surgery for breast cancer: evaluation of follow-up paradigms. Int J Clin Pract (2013) 1.39
Breast duct micro-endoscopy: a study of technique and a morphological classification of endo-luminal lesions. Breast (2005) 1.39
14. Breast cancer prevention. Int J Clin Pract (2002) 1.38
Can mood disorder in women with breast cancer be identified preoperatively? Br J Cancer (1995) 1.38
Male breast cancer. Br J Hosp Med (1993) 1.37
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet (1994) 1.33
Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet (1986) 1.29
Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet (1985) 1.26
A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer (1997) 1.26
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer (1997) 1.25
Effect of menstrual phase on surgical treatment of breast cancer. Lancet (1994) 1.24
Pleural effusion in breast cancer: a review of 105 cases. Cancer (1981) 1.24
Mastectomy or conservation for early breast cancer: psychological morbidity. Eur J Cancer (1992) 1.22
Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology (2006) 1.19
Effect of the method of biopsy on the prognosis of and reliability of receptor assays in patients with operable breast cancer. Br J Surg (1986) 1.18
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer (2010) 1.18
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet (1984) 1.18
Axillary dissection in breast cancer. Lancet (1991) 1.18
22. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract (2003) 1.17
Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cells. J Cell Physiol (1980) 1.17
A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer (1996) 1.14
In-situ breast cancer: the EORTC consensus meeting. Lancet (1989) 1.13
Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat (1985) 1.12
Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet (2008) 1.12
Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain. J Endocrinol (1988) 1.12
Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Br J Cancer (1998) 1.10
Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer (2003) 1.10
Breast cysts: a cause for rejoicing or concern? Int J Clin Pract (2007) 1.07
NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract (2008) 1.07
The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol (1988) 1.05
Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer (2002) 1.05
Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer (1994) 1.03
Foreign objects of long duration in the adult vagina. J Obstet Gynaecol (2005) 1.02
Histopathology of breast cancer in relation to age. Br J Cancer (1997) 1.01
Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg (1988) 1.00
A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol (1986) 1.00
Family history and survival in premenopausal breast cancer. Br J Cancer (1998) 0.99
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS. Br J Cancer (2002) 0.99
In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol (1986) 0.99
Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1997) 0.98
Effect of harmonic scalpel on seroma formation following surgery for breast cancer: a prospective randomized study. J BUON (2008) 0.98
Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol (1990) 0.98
The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. Eur J Cancer Clin Oncol (1987) 0.96
Relationship of blood prolactin levels and the risk of subsequent breast cancer. Int J Epidemiol (1992) 0.96
Time trends in breast cancer survival: experience in a single centre, 1975-89. Br J Cancer (1998) 0.96
The fourth EORTC DCIS Consensus meeting (Château Marquette, Heemskerk, The Netherlands, 23-24 January 1998)--conference report. Eur J Cancer (1998) 0.95
Conservative treatment of early breast cancer. Br J Hosp Med (1986) 0.95
Which patients are cured of breast cancer? Br Med J (Clin Res Ed) (1984) 0.94
Life events and breast cancer prognosis. BMJ (1992) 0.93
Optimal timing of initial breast cancer surgery. Ann Intern Med (1992) 0.91
Breast reconstruction. Int J Clin Pract (2006) 0.90
Gigantomastia unrelated to pregnancy or puberty: a case report. Breast (2002) 0.90
Sentinel node and breast cancer. Eur J Surg Oncol (2004) 0.90
Control of pleural effusions in patients with breast cancer. A randomized trial. Cancer (1983) 0.89
Generic prescribing. Br Med J (Clin Res Ed) (1986) 0.89
Prophylactic mastectomy: deliverance or delusion? We don't know, so we need to start registering all cases now. BMJ (1998) 0.89
The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients. Endocr Relat Cancer (2004) 0.89
Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Hum Biol (1998) 0.89
11. Breast cancer in young women. Int J Clin Pract (2002) 0.88
The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom). Cancer Causes Control (1993) 0.88
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial. BJOG (2005) 0.87
Gamma-glutamyl transferase: risk and prognosis of cancer. Br J Cancer (2012) 0.87
Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey. Br J Cancer (2000) 0.87
9. Arm lymphoedema following breast cancer treatment. Int J Clin Pract (2002) 0.87
Effective treatment of malignant pleural effusions. Br J Hosp Med (1987) 0.87
A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer. Br J Cancer (1994) 0.86
Prognosis of synchronous bilateral breast cancer. Br J Surg (2009) 0.86
Studies of tamoxifen in women with mastalgia. Br J Clin Pract Suppl (1989) 0.86